Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreea Varga

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Cancers|October 27, 2022
Predicting Immunotherapy Outcomes in Older Patients with Solid Tumors Using the LIPI ScoreMonica Pierro, Capucine Baldini, Edouard Auclin, et al.
Journal of Critical Care Medicine (Universitatea De Medicina Si Farmacie Din Targu-Mures)|August 17, 2023
The Gender Gap in Aortic Dissection: A Prospective Analysis of Risk and OutcomesCosmin Banceu, Marius Harpa, Klara Brinzaniuc, et al.
European Journal of Cancer (Oxford, England : 1990)|June 3, 2018
Organisational factors influencing early clinical trials enrollment: Gustave Roussy experienceSylvain Besle, Emilien Schultz, Antoine Hollebecque, et al.
Bulletin Du Cancer|January 1, 2019
Capucine Baldini, Patricia Martin Romano, Andreea Varga, et al.
Cancer|June 19, 2025
First-in-human phase 1 study of KHK2455 monotherapy and in combination with mogamulizumab in patients with advanced solid tumorsTimothy A Yap, Olivier Rixe, Capucine Baldini, et al.
Cancer Immunology, Immunotherapy : CII|July 24, 2020
Patterns of progression in patients treated for immuno-oncology antibodies combinationAlice Bernard-Tessier, Capucine Baldini, Eduardo Castanon, et al.
European Journal of Cancer (Oxford, England : 1990)|August 7, 2020
Chemotherapy beyond immune checkpoint inhibitors in patients with metastatic colorectal cancerPatricia Martin-Romano, Samy Ammari, Yolla El-Dakdoukti, et al.
Investigational New Drugs|November 3, 2017
Phase I trial of bortezomib daily dose: safety, pharmacokinetic profile, biological effects and early clinical evaluation in patients with advanced solid tumorsRastislav Bahleda, Marie-Cécile Le Deley, Apexa Bernard, et al.
European Journal of Cancer (Oxford, England : 1990)|March 7, 2020
Impact of aging on immune-related adverse events generated by anti-programmed death (ligand)PD-(L)1 therapiesCapucine Baldini, Patricia Martin Romano, Anne-Laure Voisin, et al.
European Journal of Cancer (Oxford, England : 1990)|January 22, 2022
Genome-driven medicine for patients with recurrent glioma enrolled in early phase trialsCapucine Baldini, Nadia Younan, Eduardo Castanon Alvarez, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Cancers|October 27, 2022
Predicting Immunotherapy Outcomes in Older Patients with Solid Tumors Using the LIPI ScoreMonica Pierro, Capucine Baldini, Edouard Auclin, et al.
Journal of Critical Care Medicine (Universitatea De Medicina Si Farmacie Din Targu-Mures)|August 17, 2023
The Gender Gap in Aortic Dissection: A Prospective Analysis of Risk and OutcomesCosmin Banceu, Marius Harpa, Klara Brinzaniuc, et al.
European Journal of Cancer (Oxford, England : 1990)|June 3, 2018
Organisational factors influencing early clinical trials enrollment: Gustave Roussy experienceSylvain Besle, Emilien Schultz, Antoine Hollebecque, et al.
Bulletin Du Cancer|January 1, 2019
Capucine Baldini, Patricia Martin Romano, Andreea Varga, et al.
Cancer|June 19, 2025
First-in-human phase 1 study of KHK2455 monotherapy and in combination with mogamulizumab in patients with advanced solid tumorsTimothy A Yap, Olivier Rixe, Capucine Baldini, et al.
Cancer Immunology, Immunotherapy : CII|July 24, 2020
Patterns of progression in patients treated for immuno-oncology antibodies combinationAlice Bernard-Tessier, Capucine Baldini, Eduardo Castanon, et al.
European Journal of Cancer (Oxford, England : 1990)|August 7, 2020
Chemotherapy beyond immune checkpoint inhibitors in patients with metastatic colorectal cancerPatricia Martin-Romano, Samy Ammari, Yolla El-Dakdoukti, et al.
Investigational New Drugs|November 3, 2017
Phase I trial of bortezomib daily dose: safety, pharmacokinetic profile, biological effects and early clinical evaluation in patients with advanced solid tumorsRastislav Bahleda, Marie-Cécile Le Deley, Apexa Bernard, et al.
European Journal of Cancer (Oxford, England : 1990)|March 7, 2020
Impact of aging on immune-related adverse events generated by anti-programmed death (ligand)PD-(L)1 therapiesCapucine Baldini, Patricia Martin Romano, Anne-Laure Voisin, et al.
European Journal of Cancer (Oxford, England : 1990)|January 22, 2022
Genome-driven medicine for patients with recurrent glioma enrolled in early phase trialsCapucine Baldini, Nadia Younan, Eduardo Castanon Alvarez, et al.
Pageof 5